Lv1
2 积分 2025-09-25 加入
Precision Immunotherapy to Improve Sepsis Outcomes
13小时前
求助中
Precision Immunotherapy to Improve Sepsis Outcomes
13小时前
已完结
Precision Immunotherapy to Improve Sepsis Outcomes
13小时前
已完结
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
7天前
已完结
Impact of PD-L1 on first-line osimertinib outcomes in EGFR-mutant NSCLC: real-world data from the AURORA25 study and meta-analysis
1个月前
已完结
Efficacy and safety of Syk/VEGFR-2 Dual-target Kinase Inhibitor (OT202) in Dry Eye: A Randomized, Vehicle-controlled, Phase 2 Trial
2个月前
已完结
Efficacy and safety of dotinurad versus febuxostat for the treatment of gout: a randomised, multicentre, double‐blind, phase 3 trial in China
3个月前
已完结
Fifty years devoted to anaerobes: historical, lessons, and highlights
4个月前
已完结
Empirical antibiotic therapy for sepsis: save the anaerobic microbiota
4个月前
已完结
Epidemiology and outcome of anaerobic bacteremia in a tertiary hospital
4个月前
已完结
皖公网安备34019202002308
